Rational design of shepherdin, a novel anticancer agent
- 1 May 2005
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 7 (5), 457-468
- https://doi.org/10.1016/j.ccr.2005.03.035
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Quantum Chemical Calculations and Mutational Analysis Suggest Heat Shock Protein 90 Catalyzes Trans-Cis Isomerization of GeldanamycinCell Chemical Biology, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathwaysBlood, 2004
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- ApoptosisCell, 2002
- A retro‐inverso peptide homologous to helix 1 of c‐Myc is a potent and specific inhibitor of proliferation in different cellular systemsThe FASEB Journal, 2000
- Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein SurvivinMolecular Cell, 2000
- Stepwise Assembly of a Glucocorticoid Receptor·hsp90 Heterocomplex Resolves Two Sequential ATP-dependent Events Involving First hsp70 and Then hsp90 in Opening of the Steroid Binding PocketPublished by Elsevier BV ,2000
- The Retro-inverso Form of a Homeobox-Derived Short Peptide Is Rapidly Internalized by Cultured Neurons: A New Basis for an Efficient Intracellular Delivery SystemBiochemical and Biophysical Research Communications, 1995